Literature DB >> 17044383

Unique presentation of hypereosinophilic syndrome: recurrent mitral prosthetic valve thrombosis without endomyocardial disease.

Lívia Jánoskuti1, Zsolt Förhécz, Mária Lengyel.   

Abstract

Hypereosinophilic syndrome (HES) is defined as a prolonged, unexplained peripheral eosinophilia in a patient presenting with end-organ damage. The heart is frequently involved, resulting in eosinophilic endomyocardial disease, which is characterized by mural thrombus formation and endocardial fibrosis. Thromboembolic complications in HES are mediated by material released from eosinophilic granules. Herein is reported the case of a patient who presented, 15 years after valve replacement with a mechanical prosthesis, with clinical signs of recurrent prosthetic valve thrombosis that was caused by missed hypereosinophilia. The unique feature of the case was that the mitral prosthetic valve obstruction was the result of an eosinophilic thrombus, though no tissue infiltration or inflammation had been detected by random biopsy of the left ventricular myocardium. After nine years of effective treatment of HES there were no cardiac or extracardiac complications.

Entities:  

Mesh:

Year:  2006        PMID: 17044383

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  3 in total

1.  Recurrent prosthetic heart valve thrombosis secondary to eosinophilia: a missed diagnosis.

Authors:  Nitish Rai; Shyam S Kothari
Journal:  BMJ Case Rep       Date:  2017-10-03

2.  Endomyocardial involvement in asymptomatic sub-Saharan immigrants with helminth-related eosinophilia.

Authors:  Cristina Carranza-Rodríguez; Daniel San-Román-Sánchez; Héctor Marrero-Santiago; Michele Hernández-Cabrera; Carlos Gil-Guillén; Elena Pisos-Álamo; Nieves Jaén-Sánchez; José-Luis Pérez-Arellano
Journal:  PLoS Negl Trop Dis       Date:  2017-02-24

Review 3.  Successful management of multiple permanent pacemaker complications--infection, 13 year old silent lead perforation and exteriorisation following failed percutaneous extraction, superior vena cava obstruction, tricuspid valve endocarditis, pulmonary embolism and prosthetic tricuspid valve thrombosis.

Authors:  Pankaj Kaul; Krishna Adluri; Kalyana Javangula; Wasir Baig
Journal:  J Cardiothorac Surg       Date:  2009-02-24       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.